ClinicalTrials.gg
RecruitingNCT07285720SOUNDSUpdated Dec 16, 2025

Phonological Constraints on Language Development in Individuals With Williams Syndrome

An interventional study of EEG-NIRS protocol and Questionnaire in Williams Syndrome, Language and Phonological Short-Term Memory, sponsored by Centre Hospitalier Universitaire, Amiens. Recruiting at 1 site in France. Open to participants aged 6 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-16.

Sponsored by Centre Hospitalier Universitaire, Amiens · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 4 months after the study started (first participant enrolled Jul 2024, registered Nov 2025).
  • Started Jul 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Not applicable
Ages
6 Years and older
Sex
All
01

Study summary

Williams syndrome (WS) is a neurodevelopmental disease characterized by mild to moderate intellectual disability and an extremely heterogeneous cognitive profile. Research has outlined two main features of WS: an atypical social behavior associated with surprising language abilities, and a hyperacusis. The purpose of this project is to investigate the relationships between both these abilities, and particularly the role of the hyperacusis on language abilities. The hyperacusis would be crucial in developing language skills: the apparent strength in the verbal domain could rely on Phonological Short Term Memory (PSTM) more in individuals with WS than in typically developing individuals. In addition, the investigators will compare individuals with WS to individuals with Down syndrome (DS): DS is often associated to strong limitations in the PSTM with poor language abilities. To this end, the investigators will use a highly innovative approach including physiological assessments (EEG-NIRS protocol) and questionnaires. The performance of people with WS will be compared to those of participants with DS and TD participants of same DA and cognitive assessments.

02

Conditions studied

  • Williams Syndrome
  • Language
  • Phonological Short-Term Memory
  • EEG-NIRS

Keywords

  • Williams syndrome
  • Language
  • Phonological Short-Term Memory
  • EEG-NIRS
03

In context

Williams Syndrome

29 studies on the registry are indexed under Williams Syndrome; 11 are open to participants now.

This study's planned enrollment of 130 is above the median of 60 across 12 interventional studies indexed under Williams Syndrome.

Browse Williams Syndrome studies →

Lead sponsor

Centre Hospitalier Universitaire, Amiens is the lead sponsor of 586 studies on the registry; 185 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For SW and SD: genetic diagnosis and aged between 6- and 17 years old.
  • For typical participants: any child, adolescent or young adult of the same developmental or chronological age (between 6 and 17 years of age)
  • adult group (between 20 and 60 years).

Exclusion criteria

Exclusion Criteria:

  • Autistic Associated Disorders,
  • West syndrome
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    Patients with Williams syndrome

    Other: EEG-NIRS protocol · Other: Questionnaire

  • Active comparator
    Patients with Down syndrome

    Other: EEG-NIRS protocol · Other: Questionnaire

  • Sham comparator
    Healthy children

    Other: EEG-NIRS protocol · Other: Questionnaire

  • Active comparator
    Healthy adults

    Other: EEG-NIRS protocol · Other: Questionnaire

Interventions

  • OtherEEG-NIRS protocol

    Each participant will be tested individually in a quiet room at the GRAMFC (Groupe de Recherches sur l'Analyse Multimodale de la Fonction Cérébrale, INSERM-UMR1105, Université Picardie Jules Verne and CHU Amiens-Picardie). Duration of subject's participation in the study is 120 minutes

  • OtherQuestionnaire

    Each participant will be tested individually in a quiet room at the GRAMFC (Groupe de Recherches sur l'Analyse Multimodale de la Fonction Cérébrale, INSERM-UMR1105, Université Picardie Jules Verne and CHU Amiens-Picardie). Duration of subject's participation in the study is 120 minutes

06

What researchers measure

Primary outcomes

  1. questionnaire score of patients with WS caracterisation

    questionnaire score for cognitive profile of patients with WS caracterisation

    Time frame: 2 years

Secondary outcomes

  1. Impact of hyperacusis on questionnaire score

    Impact of hyperacusis on questionnaire score

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07285720
Responsible party
Sponsor
First posted
Dec 16, 2025
Start date
Jul 5, 2024
Primary completion
Jul 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Dec 16, 2025

Study contacts

Fabrice Wallois, Pr
Contact
fabrice.wallois@u-picardie.fr
33+3 22 08 77 75

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion